Ivan F Loncarevic

Ivan F Loncarevic

UNVERIFIED PROFILE

Are you Ivan F Loncarevic?   Register this Author

Register author
Ivan F Loncarevic

Ivan F Loncarevic

Publications by authors named "Ivan F Loncarevic"

Are you Ivan F Loncarevic?   Register this Author

16Publications

249Reads

15Profile Views

Tapping an unexploited repository: Carnoy's fixed cell pellets for proteomic biomarker research in leukemia.

Mol Med Rep 2008 Jul-Aug;1(4):585-7

Core Unit Chip Application, Institute of Human Genetics and Anthropology, Klinikum der FSU Jena, D-07740 Jena, Germany.

View Article

Download full-text PDF

Source
October 2012

BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML.

Int J Oncol 2011 Sep 1;39(3):585-91. Epub 2011 Jun 1.

Institute of Human Genetics, Jena University Hospital, Kollegiengasse 10, D-07743 Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2011.1062DOI Listing
September 2011

Number of genomic imbalances correlates with the overall survival for adrenocortical cancer in childhood.

Pediatr Blood Cancer 2008 Sep;51(3):356-62

Institute for Human Genetics and Anthropology, Clinical University Hospital, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21603DOI Listing
September 2008

Cytogenetic characterisation and proteomic profiling of the Imatinib-resistant cell line KCL22-R.

Int J Oncol 2007 Jul;31(1):121-8

Core Unit Chip Application, Institute of Human Genetics and Anthropology, Jena, Germany.

View Article

Download full-text PDF

Source
July 2007

Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes.

Neoplasia 2006 Nov;8(11):933-8

Core Unit Chip Application, Institute of Human Genetics and Anthropology, Friedrich Schiller University, Jena 07740, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1593/neo.06451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716012PMC
November 2006

Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia.

Leuk Res 2005 Jul;29(7):849-53

Department of Internal Medicine II Oncology and Hematology, Friedrich Schiller University, Erlanger Allee 101, 07740 Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2004.12.001DOI Listing
July 2005

Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation.

J Cancer Res Clin Oncol 2005 May 11;131(5):279-83. Epub 2005 Jan 11.

Department of Internal Medicine II (Oncology and Hematology), Friedrich Schiller University, Erlanger Allee 101, 07740 Jena, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-004-0660-x
Publisher Site
http://dx.doi.org/10.1007/s00432-004-0660-xDOI Listing
May 2005

Characterization of a highly aberrant plasma cell leukemia karyotype: a case report.

Oncol Rep 2004 Jan;11(1):89-92

Institute of Human Genetics and Anthropology, Jena, Germany.

View Article

Download full-text PDF

Source
January 2004